Inspire proposes follow-on

Inspire Pharmaceuticals Inc. (NASDAQ:ISPH) proposed late Tuesday to raise $80 million in a follow-on underwritten by Deutsche Bank. Inspire promotes AzaSite for bacterial conjunctivitis and co-promote...